MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...

Page created by Earl Mills
 
CONTINUE READING
MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...
MINOCA: diagnosi, terapia e follow-up
            Alessandra Chinaglia
MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...
MINOCA = Myocardial infarction with non-obstructive coronary arteries

                 ….senza ostruzione coronarica > 50%
MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...
Quanti sono i MINOCA ?

SWEDEHEART registry

5830 (9.6%) / 60,467 patients
                                                       1/10 dei pazienti con IMA
The American Journal of Medicine (2018) 131, 524–532

Japanese ROADDPC discharge database

 14,045 (10.2%) / 137,678 AMI patients
 International Journal of Cardiology xxx (xxxx) xxx
MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...
28 publications

                             MINOCA più donne e più giovani
                             di IMA con ostruzione coronarica

                  Circulation. 2015;131:861-870. DOI: 10.1161/
MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...
1. Diagnosi
2. Prognosi
3. Terapia
MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...
58 anni, maschio
In PS per episodio di intenso dolore epigastrico, dispnea e malessere
Ipertensione arteriosa in terapia, obesità
Da 4 giorni episodi di dolore epigastrico oppressivo con dispnea, sempre da sforzo, a rapida regressione con il riposo

                                                                         Troponina 0.7 (< 0.1)

                                                                         D-dimero>2000
MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...
MINOCA is a working diagnosis and should lead the treating physician to
investigate underlying causes

  NON CARDIACHE            CARDIACHE                  CORONARICHE
                           NON CORONARICHE
  Embolia polmonare                                   Dissezione coronarica
  Trombofilie              Miocardite                 Spasmo coronarico
  IMA di tipo II           Takotsubo                  Embolia coronarica
  Anemia                   FA tachicardica            Placca ulcerata non
  Ins. Respiratoria        Stenosi aortica            ostruttiva
  Shock
  Ipertensione
  Sepsi
  Catecolamine
MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...
MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...
RMN permette di escludere
            miocardite nel 33%

Circulation. 2015;131:861-870. DOI: 10.1161/
MINOCA: diagnosi, terapia e follow-up - Alessandra Chinaglia - Cardio ...
388 consecutive patients with MINOCA
Age 56 ± 17

                                              Capacità della RMN di
 25% myocarditis                              identificare la causa in
 25% MI
                                              elevata % di casi
 25% cardiomyopathy
 26% normal CMR

performed at a median of
37 days from presentation

                                       J Am Coll Cardiol Img 2019;12:1973–82
Spasmo coronarico in 1 caso su 4

Circulation. 2015;131:861-870. DOI: 10.1161/
80 MINOCA patients
mean age 63.0± 10.7 years, 40 (50%) male

Acetylcholine test in 43 (53.7%) patients
Ergonovine test in 37 (46.3%) patients

positive in 37 (46.2%)

European Heart Journal (2018) 39, 91–98
European Heart Journal (2018) 39, 91–98
Trombofiia nel 14% dei casi

Circulation. 2015;131:861-870. DOI: 10.1161/
European Heart Journal (2017) 38, 143–153
1. Diagnosi
2. Prognosi
3. Terapia
Mortalità MINOCA minore di IMA
          con ostruzione coronarica
          ma significativa

Circulation. 2015;131:861-870. DOI: 10.1161/
SWEDEHEART

              Mortalità CV, IMA, e HF nei
              MINOCA minore di IMA
              con ostruzione coronarica
              ma maggiore dei pazienti non IMA

Journal of Internal Medicine, 2019, 285; 419–428/
SWEDEHEART

MACEwas defined as all-cause mortality, rehospitalization for acute MI, ischemic stroke and heart failure.

                                               2147 patients (24%) experienced a new MACE and 1254 patients (14%) died during the mean
                                               follow-up of 4.5 years

                                          Age, smoking, previous MI, ECG changes at
                                          admission, reduced LVEF, creatinine, CRP
                                          Age, diabetes, hypertension, smoking, previous MI, previous
                                          stroke, COPD, PVD, dementia, previous or present cancer, ECG
                                          changes at admission, reduced LVEF, creatinine, CRP and
                                          lower levels of total cholesterol.

                                                                 International Journal of Cardiology 261 (2018) 18–23
SWEDEHEART

                                                                                      Valore di troponina aiuta a
                                                                                      stratificare il rischio

             Q1:
acute myocardial infarction patients aged 18 to 55 years
299 2690 (11.1%) MINOCA

                                                           J Am Heart Assoc. 2018;7: e009174
MH mental health
RE role emotional;
SF social function
VT vitality
                     Am J Cardiol 2017;120:341e346
SWEDEHEART

9092 patients with MINOCA
570 (6.3%) MINOCA patients hospitalized due to a recurrent MI

                                                                The American Journal of Medicine (2019) 132:335−346
1. Diagnosi
2. Prognosi
3. Terapia
TERAPIA IN BASE ALLA DIAGNOSI
SWEDEHEART

5830 patients MINOCA vs 54,637 AMI CAD
                         follow-up at 6 to 10 weeks after the hospitalization

                                                       The American Journal of Medicine (2018) 131, 524–532
SWEDEHEART

Blood pressure; LDL cholesterol levels in the target ranges,
nonsmoking, and participation in exercise training.

                                                               The American Journal of Medicine (2018) 131, 524–532
SWEDEHEART registry

STATINE         ACE INIBITORI
                                  La terapia con statine,
                                  ACE inibitori e
                                  betabloccanti potrebbe
                                  essere favorevole

BETABLOCCANTI   DAPT

                                  Circulation. 2017;135:1481–1489.
Conclusioni

• MINOCA = danno ischemico miocardico senza ostruzione coronarica
• Eziologia eterogenea (cause coronariche, cardiache, non cardiache,
  IMA II tipo)
• Necessario approfondire la diagnosi eziologica (Cath lab, CMR, Lab,
  Clinica)
• Prognosi non sempre buona
• Predittori: fattori di rischio, troponina
• Terapia: 1) eziologica 2) controllo dei fattori di rischio
The diagnosis of MINOCA, like the diagnosis of
MI, indicates that there is an ischemic mechanism responsible
for the myocyte injury (ie, nonischemic causes
such as myocarditis have been excluded). Furthermore,
the diagnosis of MINOCA necessitates that obstructive
CAD has not been inadvertently overlooked (eg, spontaneous
coronary artery dissection). The prevalence of
MINOCA is estimated to be 6% to 8% among patients
diagnosed with MI and more common in women than
men, as well as in patients presenting with NSTEMI
compared with those presenting with STEMI.96–98 Atherosclerotic
plaque disruption and coronary thrombosis
may be a cause of MINOCA (ie, type 1 MI). However,
coronary spasm and spontaneous coronary dissection
may be involved as well (ie, type 2 MI). along with other
possible causes. Additional coronary imaging and functional
testing methods may be useful to elucidate the
mechanisms of ischemia in MINOCA.46
European Heart Journal: Acute Cardiovascular Care
2019, Vol. 8(1) 54–
2690 patients undergoing angiography, 2374 (88.4%) had
acute myocardial infarction patients aged 18 to 55 years      MICAD,
                                                              299 (11.1%) had MINOCA, and 17 (0.6%) remained unclassified
                                                              Women had 5 times higher odds of having MINOCA than men
                                                              (14.9% versus 3.5%; odds ratio: 4.84; 95% confidence interval,
                                                              3.29–7.13).

                                                           J Am Heart Assoc. 2018;7:
                                                           e009174
SWEDEHEART

9092 unique patients with MINOCA of 199,163 MI admissions
in total. The 570 (6.3%) MINOCA
patients who were hospitalized due to a recurrent MI
constituted the study group.

                                                            The American Journal of Medicine (2019) 132:335−346
European Heart Journal: Acute Cardiovascular Care
2019, Vol. 8(1) 54–
SWEDEHEART
Out of 199,163 MI admissions, 9092 consecutive unique
patientswith MINOCA were identified. The mean agewas 65.5 years and 62%werewomen.

                                                                     International Journal of Cardiology 261 (2018) 18–23
Consecutive patients with acute myocardial infarction admitted
to a cardiac unit at all 73 hospitals in Sweden between January
1, 2011 and December 31, 2013
SWEDEHEART registry

                                                                  The American Journal of Medicine, Vol 129, No 4, April 2016
You can also read